Division of Infectious Diseases and International Medicine, Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
Department of Immunology, College of Basic Medical Sciences, China Medical University, Shenyang, 110001, China.
Parasit Vectors. 2020 Feb 12;13(1):67. doi: 10.1186/s13071-020-3934-5.
The malaria elimination plan of the Greater Mekong Subregion (GMS) is jeopardized by the increasing number of Plasmodium vivax infections and emergence of parasite strains with reduced susceptibility to the frontline drug treatment chloroquine/primaquine. This study aimed to determine the evolution of the P. vivax multidrug resistance 1 (Pvmdr1) gene in P. vivax parasites isolated from the China-Myanmar border area during the major phase of elimination.
Clinical isolates were collected from 275 P. vivax patients in 2008, 2012-2013 and 2015 in the China-Myanmar border area and from 55 patients in central China. Comparison was made with parasites from three border regions of Thailand.
Overall, genetic diversity of the Pvmdr1 was relatively high in all border regions, and over the seven years in the China-Myanmar border, though slight temporal fluctuation was observed. Single nucleotide polymorphisms previously implicated in reduced chloroquine sensitivity were detected. In particular, M908L approached fixation in the China-Myanmar border area. The Y976F mutation sharply decreased from 18.5% in 2008 to 1.5% in 2012-2013 and disappeared in 2015, whereas F1076L steadily increased from 33.3% in 2008 to 77.8% in 2015. While neutrality tests suggested the action of purifying selection on the pvmdr1 gene, several likelihood-based algorithms detected positive as well as purifying selections operating on specific amino acids including M908L, T958M and F1076L. Fixation and selection of the nonsynonymous mutations are differently distributed across the three border regions and central China. Comparison with the global P. vivax populations clearly indicated clustering of haplotypes according to geographic locations. It is noteworthy that the temperate-zone parasites from central China were completely separated from the parasites from other parts of the GMS.
This study showed that P. vivax populations in the China-Myanmar border has experienced major changes in the Pvmdr1 residues proposed to be associated with chloroquine resistance, suggesting that drug selection may play an important role in the evolution of this gene in the parasite populations.
大湄公河次区域(GMS)的疟疾消除计划正受到越来越多的间日疟原虫感染和对抗疟一线药物氯喹/伯氨喹敏感性降低的寄生虫株出现的威胁。本研究旨在确定在中国-缅甸边境地区消除疟疾的主要阶段从 2008 年、2012-2013 年和 2015 年采集的间日疟原虫临床分离株中发现的间日疟原虫多药耐药 1 型(Pvmdr1)基因的进化情况。
从中国-缅甸边境地区 275 例间日疟患者和中国中部 55 例患者中采集临床分离株。并与泰国三个边境地区的寄生虫进行比较。
总体而言,所有边境地区的 Pvmdr1 基因遗传多样性都相对较高,在中国-缅甸边境地区的七年时间里,虽然观察到轻微的时间波动。检测到先前与降低氯喹敏感性相关的单核苷酸多态性。特别是,M908L 在中缅边境地区接近固定。2008 年 Y976F 突变从 18.5%急剧下降到 2012-2013 年的 1.5%,并于 2015 年消失,而 F1076L 则从 2008 年的 33.3%稳步上升到 2015 年的 77.8%。尽管中性检验表明 pvmdr1 基因受到了纯化选择的作用,但几种基于似然的算法检测到特定氨基酸上存在正选择和纯化选择,包括 M908L、T958M 和 F1076L。非同义突变的固定和选择在三个边境地区和中国中部的分布不同。与全球间日疟原虫种群的比较清楚地表明,根据地理位置对单倍型进行聚类。值得注意的是,来自中国中部的温带地区寄生虫与大湄公河次区域其他地区的寄生虫完全分离。
本研究表明,中国-缅甸边境地区的间日疟原虫种群在 Pvmdr1 残基上发生了重大变化,这些残基被认为与氯喹耐药有关,这表明药物选择可能在寄生虫种群中该基因的进化中发挥了重要作用。